天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> journal list >> Fertility and sterility >>article
Fertility and sterility

Fertility and sterility

IF: 6.59
Download PDF

Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?

Published:1 May 2018 DOI: 10.1016/j.fertnstert.2018.03.034 PMID: 29778368
Georg Griesinger M.D. , Christophe Blockeel M.D. , Herman Tournaye M.D.

Abstract

Oral dydrogesterone has been used for luteal phase support on an empirical basis since the early days of in?vitro fertilization (IVF) treatment. Systematic comparisons of oral dydrogesterone with vaginal progesterone, so far considered to be the standard of care, started to appear in the middle 2000s. Recently, a large, randomized, double-blind, double-dummy phase III trial on the use of daily 30?mg oral dydrogesterone versus daily 600?mg micronized vaginal progesterone for LPS in IVF was published. This company-sponsored trial confirmed the efficacy findings from previous independent researchers and firmly established the noninferiority of daily 30?mg oral dydrogesterone for luteal phase support. Despite oral administration and first pass through the liver, dydrogesterone was as well tolerated as vaginal progesterone in safety analyses. Moreover, no new fetal safety concerns have arisen from that trial. Given the widespread preference of women for an oral compound, dydrogesterone may well become the new standard for luteal phase support in fresh embryo transfer IVF cycles.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Progesterone 57-83-0 C21H30O2 923 suppliers $20.00-$814.00
Dydrogesterone 152-62-5 C21H28O2 315 suppliers $49.00-$1950.00

Similar articles

IF:3.8

A rapid method for detecting bronopol in fresh fish, shrimp, crab, and shellfish samples using liquid chromatography-tandem mass spectrometry

Neural Regeneration Research Mengqiang Wang , Li Jia ,etc Published: 8 November 2023
IF:2.5

Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen.

Neural Regeneration Research Per Ertzgaard, Claudia Campo,etc Published: 6 March 2017
IF:3.5

Clascoterone: a new topical anti-androgen for acne management

Neural Regeneration Research Parvathy Santhosh MD, Mamatha George MD,etc Published: 9 July 2021